×
About 24,163 results

ALLMedicine™ Venous Thromboembolism Center

Research & Reviews  8,109 results

Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed w...
https://doi.org/10.1093/ptj/pzac057
Physical Therapy; Hillegass E, Lukaszewicz K et. al.

May 15th, 2022 - No matter the practice setting, physical therapists work with patients who are at risk for or who have a history of venous thromboembolism (VTE). In 2016, the first clinical practice guideline (CPG) addressing the physical therapist management of ...

Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chem...
https://doi.org/10.1007/s00520-022-07096-1 10.1007/s11239-015-1311-6 10.1634/theoncologist.2015-0361 10.1200/JCO.2005.03.8877 10.1182/blood.2020007338 10.1160/TH16-08-0615 10.1007/s00520-018-4602-6 10.1007/s00520-021-06598-8 10.1007/s11912-019-0767-5 10.1007/s12272-017-0976-0 10.1038/bjc.2013.48 10.1177/2047487319891780 10.1007/s11548-010-0526-4 10.1161/01.CIR.0000122870.22669.4a 10.1634/theoncologist.2013-0239 10.1016/j.blre.2019.03.005 10.1111/jth.15367 10.1016/s1470-2045(13)70579-5 10.1177/1758835918818347 10.1007/s10637-012-9878-7 10.1007/s40262-020-00930-x 10.4172/2155-9864.1000202 10.1200/JCO.2014.58.7550 10.1002/phar.2213 10.1007/s00520-017-4034-8 10.3892/etm.2019.8019 10.3389/fneur.2018.01067 10.1038/s41416-019-0510-x 10.1182/asheducation-2018.1.339 10.3322/caac.21654 10.3322/caac.20073 10.1097/JTO.0b013e31811ea275 10.1038/bjc.2016.143 10.1378/chest.13-2379 10.1111/j.1538-7836.2010.03929.x 10.1016/j.thromres.2019.11.009 10.1159/000046586 10.1200/JCO.2009.22.3271 10.1111/j.1538-7836.2004.00928.x 10.1002/cncr.21496 10.1038/s41416-018-0027-8 10.1111/jth.13752 10.1001/jama.293.6.715 10.1001/archinte.164.2.190 10.1161/ATVBAHA.120.314378 10.1177/1358863X14568705 10.1182/blood-2018-99-116439 10.4103/jcrt.JCRT_121_18 10.21873/anticanres.13954 10.1200/JCO.19.01461 10.1007/s00520-017-3990-3 10.1007/s00432-016-2131-6 10.5114/wo.2013.33766 10.1093/ajhp/58.17.1614 10.3892/ol.2022.13235 10.1177/1076029617729215 10.1007/s00520-012-1590-9 10.1016/j.thromres.2014.02.020 10.3892/ijo.2014.2803 10.1056/NEJMoa1108898 10.1016/S1470-2045(09)70232-3 10.31887/DCNS.2011.13.2/npatsopoulos
Supportive Care in Cancer : Official Journal of the Multi... Xynogalos S, Simeonidis D et. al.

May 14th, 2022 - Patients with active cancer have a 4-sevenfold increased risk for venous thromboembolism (VTE) especially during systematic anticancer treatment. Simultaneously, surgery is an additional risk factor. The Metaxas's Hospital THromboprophylaxis progr...

Prediction of venous thromboembolism in patients with multiple myeloma treated with len...
https://doi.org/10.1111/jth.15758
Journal of Thrombosis and Haemostasis : JTH; Chalayer E, Talbot A et. al.

May 14th, 2022 - Venous thromboembolism (VTE) is a concern for patients with newly diagnosed multiple myeloma. We aimed to evaluate VTE incidence, risk factors and risk score. We performed a substudy of the 'Intergroupe Francophone du Myelome 2009' randomized cont...

see more →

Guidelines  54 results

American Society of Hematology living guidelines on the use of anticoagulation for thro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566097
Blood Advances; Cuker A, Tseng EK et. al.

Nov 3rd, 2021 - COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care pr...

American Society of Hematology living guidelines on the use of anticoagulation for thro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416320
Blood Advances; Cuker A, Tseng EK et. al.

Sep 3rd, 2021 - COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care...

A modeling approach to derive baseline risk estimates for GRADE recommendations: Concep...
https://doi.org/10.1016/j.jclinepi.2021.07.010
Journal of Clinical Epidemiology; Morgano GP, Wiercioch W et. al.

Jul 21st, 2021 - The goal of this study was to develop an approach that can be used where baseline risk estimates that are directly applicable to prioritized patient-important outcomes are not available from published studies. The McMaster University GRADE Centre ...

American Society of Hematology 2021 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903232
Blood Advances; Lyman GH, Carrier M et. al.

Feb 12th, 2021 - Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. These evidence-based guidelines of the American Society of Hematology (ASH...

Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncolog...
https://doi.org/10.1016/j.ygyno.2020.11.020
Gynecologic Oncology; Gressel GM, Marcus JZ et. al.

Dec 2nd, 2020 - Venous thromboembolism (VTE) is a common cause of morbidity and mortality in women with gynecologic malignancies. This practice statement provides clinical data and overall quality of evidence regarding the use of direct oral anticoagulants (DOACs...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  215 results

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
https://clinicaltrials.gov/ct2/show/NCT03080883

May 11th, 2022 - PRIMARY OBJECTIVE: I. Any episode of major bleeding including fatal bleeding or clinically relevant non-major bleeding. SECONDARY OBJECTIVES: I. The proportion of patients who experienced at least one such bleeding event within 6 months of beginni...

Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
https://clinicaltrials.gov/ct2/show/NCT04153760

May 6th, 2022 - The purpose of the pilot PARTUM trial is to determine whether it is feasible to conduct a larger randomized controlled trial to determine whether low-dose aspirin is efficacious and safe at preventing postpartum venous thromboembolism (VTE) in wom...

The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients
https://clinicaltrials.gov/ct2/show/NCT05246943

May 2nd, 2022 - This will be a quantitative prospective cohort study conducted at the University of Texas Medical Branch (UTMB) Galveston and League City campuses. Candidates include subjects who will have elective colorectal surgery at UTMB. This study looks to ...

Short-term Clinical Deterioration After Acute Pulmonary Embolism
https://clinicaltrials.gov/ct2/show/NCT03915925

Apr 27th, 2022 - The objective of this study is to compare right ventricular dysfunction (RVD)dependent and independent prognostic models for short-term serious adverse events in pulmonary embolism (PE) patients. The target population is emergency department (ED) ...

Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients
https://clinicaltrials.gov/ct2/show/NCT05347550

Apr 26th, 2022 - Hospital acquired thrombosis describes blood clots that form in the legs and lungs after someone is treated in hospital. Clots in the leg can cause swelling, pain and other problems. If a clot in the leg travels to the lungs, it may be life threat...

see more →

News  1,268 results

Consider Cancer as a Trigger for Deep Vein Thrombosis
https://www.medscape.com/viewarticle/973912

May 12th, 2022 - Core Messages If no triggering event can be identified for a patient with deep vein thrombosis, an unknown cancer should be considered as a cause. Rosemary Poulose and L. Christian Napp, MD, et al from Hannover Medical School in Germany recalled t...

Non-O Blood Type May Increase VTE Risk in Patients With Cancer
https://www.medscape.com/viewarticle/972800

Apr 27th, 2022 - Venous thromboembolism (VTE) is common in patients with cancer and can increase the risk of dying, as well as interfering with treatment and increasing the cost of treatment. New findings suggest that patients with cancer who have non-O blood type...

Abemaciclib+ET shows a manageable safety profile in HR+/HER2-, high-risk early breast cancer
https://www.mdedge.com/hematology-oncology/article/254054/breast-cancer/abemaciclibet-shows-manageable-safety-profile-hr

Apr 25th, 2022 - Key clinical point: Adjuvant abemaciclib plus endocrine therapy (ET) showed a manageable and acceptable safety profile in patients with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-), high-risk, early breast canc.

Full Vaccination Can Cut Risk of Outpatient COVID-Related VTE
https://www.medscape.com/viewarticle/971749

Apr 7th, 2022 - The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways In a UK Biobank cohort, ambulatory patients with mild COVID-19 were 20 times more likely to develop venous thromboemboli...

POISE-3 Backs Wider Use of Tranexamic Acid in Noncardiac Surgery 
https://www.medscape.com/viewarticle/971483

Apr 2nd, 2022 - The antifibrinolytic tranexamic acid (TXA) reduced serious bleeding without a significant effect on major vascular outcomes in patients undergoing noncardiac surgery at risk for these complications in the POISE-3 trial. TXA cut the primary efficac...

see more →

Patient Education  2 results see all →